Clinical Trials Browser

Completed × INDUSTRY × Colony-Stimulating Factors × Clear all

NCT01265901 2017-10-12

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

Phase 3 Completed

Carcinoma, Renal Cell

NCT01368276 2015-12-18

An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma

Phase 3 Completed

31 enrolled 11 charts

Melanoma